MULTIPLE MYELOMA, REFRACTORY
Clinical trials for MULTIPLE MYELOMA, REFRACTORY explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE MYELOMA, REFRACTORY trials appear
Sign up with your email to follow new studies for MULTIPLE MYELOMA, REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody combo offers hope for hard-to-treat multiple myeloma
Disease control ENROLLING_BY_INVITATIONThis study is for people with multiple myeloma that has returned or stopped responding to prior treatments. Researchers want to see if adding a new antibody drug called HuL001 to two standard medications (lenalidomide and dexamethasone) is safe and can shrink the cancer. About 21…
Matched conditions: MULTIPLE MYELOMA, REFRACTORY
Phase: PHASE1, PHASE2 • Sponsor: HuniLife Biotechnology, Inc. • Aim: Disease control
Last updated May 17, 2026 11:49 UTC
-
Website aims to empower myeloma patients to take charge of their health
Knowledge-focused OngoingThis study looks at whether a health technology program called All4Cure helps people with multiple myeloma become more involved in managing their own health. About 200 participants will fill out surveys over time to measure their confidence and ability to take action, as well as …
Matched conditions: MULTIPLE MYELOMA, REFRACTORY
Sponsor: All4Cure • Aim: Knowledge-focused
Last updated May 17, 2026 11:37 UTC